Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

Phase 3Not Yet RecruitingNCT06902714

University of Alabama at Birmingham60 enrolled

Overview

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Shoulder Arthroplasty

Interventions

oral tranexamic acidDRUG

one group of subjects will receive oral tranexamic acid and the other will receive oral placebo

PlaceboDRUG

one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty Exclusion Criteria: * Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Outcomes

Primary Outcomes

VAS

visual analog scale

Time frame: 2 weeks

Central Contacts

Walter Smith

CONTACT

205-930-8554 waltersmith@uabmc.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.